The antiviral effects of RSV fusion inhibitor, MDT ‐637, on clinical isolates, versus its achievable concentrations in the human respiratory tract and comparison to ribavirin

This article is protected by copyright. All rights reserved.

Source: Influenza and Other Respiratory Viruses - September 1, 2017 Category: Virology Authors: Young ‐In Kim, Rajat Pareek, Ryan Murphy, Lisa Harrison, Eric Farrell, Robert Cook, John DeVincenzo Tags: Original Article Source Type: research